Walgreens Store Sales Seen as Hurdle for Rite Aid ApprovalBy
U.S antitrust agency expected to review effect on drug costs
Losing the No. 3 drug store would leave two major competitors
Walgreens Boots Alliance Inc.’s deal to acquire Rite Aid Corp. is expected to draw antitrust scrutiny not only because the company would grow to 12,700 locations, but because of what goes on behind the scenes with drug payments.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.